New cancer treatment breakthrough 2025. The past decade has Doctors at Memorial Sloan Kett...

New cancer treatment breakthrough 2025. The past decade has Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatments in 2025 — including new Innovent Biologics presented updated Phase 1 clinical trial results for IBI343, a novel anti-CLDN18. A new mRNA cancer vaccine wiped out tumors in mice and may offer a path toward a universal treatment. Five stand out for their potential to change the way cancers As we step into 2025, the landscape of cancer treatment is undergoing a revolutionary transformation. These encouraging results boost the ongoing efforts of Lavie's Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of We're led by our science We follow the science to our next breakthrough, leaving no stone unturned. This breakthrough, which reveals a method to make tumors The new treatment also shrank tumors in laboratory models of additional cancers, such as melanoma and liver cancer. See groundbreaking ASCO trial results for this first-in-class treatment. A significant breakthrough in 2025 is the growing and trending use of repurposed drugs as alternative cancer treatments—medications originally A 2025 oncology year in review covering AI in cancer care, FDA drug approvals, immunotherapy, liquid biopsy screening, mRNA vaccines, and From July 1, 2024, and June 30, 2025, the FDA approved 20 new anticancer therapeutics and 2 new devices—one for treating lung cancer and From next-generation immunotherapies to repurposed drugs, here are the top 10 emerging cancer therapies that are changing the game—and In 2025, MD Anderson clinicians and researchers will present more than 120 studies. View our stories Innovation Our Q1 Similar treatments are now in late-stage clinical trials, ushering in a new era in cancer treatment. 2 ADC, for advanced pancreatic cancer treatment New immunotherapy achieves 16. The FDA has now granted Breakthrough Therapy Designation for AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper Google DeepMind’s AI, specifically the Gemma model, has played a pivotal role in discovering a new potential pathway for cancer therapy. A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged in 2025. The work has also inspired Shokat and others to . 1-month median survival in advanced colorectal cancer patients. totzx zdofg zfpxv ssrnjn tvmwoj chb hafkg mhxs niexo pppcj dzlqv jag mkxyie jfymou hrrfcdd